Darren Bentley

690 total citations
24 papers, 532 citations indexed

About

Darren Bentley is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Darren Bentley has authored 24 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Darren Bentley's work include Drug Transport and Resistance Mechanisms (4 papers), CRISPR and Genetic Engineering (3 papers) and Receptor Mechanisms and Signaling (3 papers). Darren Bentley is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), CRISPR and Genetic Engineering (3 papers) and Receptor Mechanisms and Signaling (3 papers). Darren Bentley collaborates with scholars based in Switzerland, United Kingdom and United States. Darren Bentley's co-authors include Stefan Selbert, David W. Melton, Kay Samuel, John D. Ansell, J. Kirsty Millar, N Hole, Jim Selfridge, Martin Waterfall, Nicola J. Redhead and Michael Dodds and has published in prestigious journals such as Nature Genetics, Scientific Reports and Journal of Cell Science.

In The Last Decade

Darren Bentley

23 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darren Bentley Switzerland 12 272 146 63 54 43 24 532
Zakia Shinwari Saudi Arabia 15 293 1.1× 73 0.5× 54 0.9× 78 1.4× 25 0.6× 31 552
Marion Ganslmayer Germany 14 433 1.6× 153 1.0× 61 1.0× 43 0.8× 36 0.8× 37 802
Jaehwi Song South Korea 13 471 1.7× 104 0.7× 77 1.2× 37 0.7× 24 0.6× 18 616
Steven V. Molinski Canada 14 334 1.2× 182 1.2× 27 0.4× 51 0.9× 28 0.7× 19 874
Reyaz ur Rasool India 17 370 1.4× 174 1.2× 97 1.5× 22 0.4× 31 0.7× 26 694
Khurum Khan United Kingdom 10 289 1.1× 226 1.5× 128 2.0× 55 1.0× 21 0.5× 28 567
Yusuke Nakamura Japan 13 414 1.5× 179 1.2× 61 1.0× 71 1.3× 13 0.3× 38 734
Guadalupe Domínguez-Gómez Mexico 16 373 1.4× 135 0.9× 200 3.2× 28 0.5× 28 0.7× 38 678
Kimberly L. Moulton United States 4 303 1.1× 90 0.6× 98 1.6× 35 0.6× 12 0.3× 6 527
Katharina R. Beck Switzerland 15 185 0.7× 41 0.3× 48 0.8× 35 0.6× 50 1.2× 22 539

Countries citing papers authored by Darren Bentley

Since Specialization
Citations

This map shows the geographic impact of Darren Bentley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darren Bentley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darren Bentley more than expected).

Fields of papers citing papers by Darren Bentley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darren Bentley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darren Bentley. The network helps show where Darren Bentley may publish in the future.

Co-authorship network of co-authors of Darren Bentley

This figure shows the co-authorship network connecting the top 25 collaborators of Darren Bentley. A scholar is included among the top collaborators of Darren Bentley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darren Bentley. Darren Bentley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bentley, Darren. (2024). Revisiting the Checkerboard to Inform Development of β-Lactam/β-Lactamase Inhibitor Combinations. Antibiotics. 13(4). 337–337. 1 indexed citations
3.
McCabe, Michael T., Geraldine Ferron‐Brady, Paul Martin, et al.. (2024). Momelotinib: Mechanism of action, clinical, and translational science. Clinical and Translational Science. 17(8). e70018–e70018. 5 indexed citations
4.
5.
Meneses‐Lorente, Georgina, Darren Bentley, Elena Guerini, et al.. (2021). Characterization of the pharmacokinetics of entrectinib and its active M5 metabolite in healthy volunteers and patients with solid tumors. Investigational New Drugs. 39(3). 803–811. 26 indexed citations
6.
Hipp, Joerg F., Frédéric Knoflach, Robert A. Comley, et al.. (2021). Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man. Scientific Reports. 11(1). 7700–7700. 24 indexed citations
7.
Bentley, Darren, et al.. (2020). PKPD and cardiac single cell modeling of a DDI study with a CYP3A4 substrate and itraconazole to quantify the effects on QT interval duration. Journal of Pharmacokinetics and Pharmacodynamics. 47(5). 447–459. 1 indexed citations
8.
Smith, Patrick F., Michael Dodds, Darren Bentley, Karen Rowland Yeo, & Craig R. Rayner. (2020). Dosing will be a key success factor in repurposing antivirals for COVID‐19. British Journal of Clinical Pharmacology. 87(9). 3451–3454. 25 indexed citations
9.
Black, Donald M., Darren Bentley, Sunny Chapel, et al.. (2018). Clinical Pharmacokinetics and Pharmacodynamics of Dalcetrapib. Clinical Pharmacokinetics. 57(11). 1359–1367. 13 indexed citations
10.
Stillhart, Cordula, Neil Parrott, Marc Lindenberg, et al.. (2017). Characterising Drug Release from Immediate-Release Formulations of a Poorly Soluble Compound, Basmisanil, Through Absorption Modelling and Dissolution Testing. The AAPS Journal. 19(3). 827–836. 27 indexed citations
11.
Theron, Michel, Darren Bentley, Marianne Manchester, et al.. (2017). Pharmacodynamic Monitoring of RO5459072, a Small Molecule Inhibitor of Cathepsin S. Frontiers in Immunology. 8. 806–806. 36 indexed citations
12.
Kuhlmann, Olaf, David Carlile, Johannes Noé, & Darren Bentley. (2014). Interaction potential of Carmegliptin with P-glycoprotein (Pgp) transporter in healthy volunteers. PubMed. 3(1). 28–37. 3 indexed citations
13.
Anzures‐Cabrera, Judith, et al.. (2013). In vivo evaluation of drug-drug interactions linked to UGT inhibition: the effect of probenecid on dalcetrapib pharmacokinetics. International Journal of Clinical Pharmacology and Therapeutics. 51(3). 215–218. 10 indexed citations
14.
Phelan, Mary C., Judith Anzures‐Cabrera, David Carlile, et al.. (2013). Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dalcetrapib. Clinical Pharmacokinetics. 52(4). 255–265. 10 indexed citations
15.
Bentley, Darren, et al.. (2012). Evidence of a Drug–Drug Interaction Linked to Inhibition of Ester Hydrolysis by Orlistat. Journal of Cardiovascular Pharmacology. 60(4). 390–396. 22 indexed citations
16.
Bentley, Darren, et al.. (2011). No Evidence of QT Prolongation With Supratherapeutic Doses of Aleglitazar. Journal of Cardiovascular Pharmacology. 59(3). 288–297. 2 indexed citations
17.
18.
Bentley, Darren, Nicola J. Redhead, Kay Samuel, et al.. (2002). DNA ligase I null mouse cells show normal DNA repair activity but altered DNA replication and reduced genome stability. Journal of Cell Science. 115(7). 1551–1561. 69 indexed citations
19.
Selbert, Stefan & Darren Bentley. (1998). Efficient BLG-Cre Mediated Gene Deletion in the Mammary Gland. Transgenic Research. 7(5). 387–398. 84 indexed citations
20.
Bentley, Darren, Jim Selfridge, J. Kirsty Millar, et al.. (1996). DNA ligase I is required for fetal liver erythropoiesis but is not essential for mammalian cell viability. Nature Genetics. 13(4). 489–491. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zakia Shinwari Breakdown of academic impact, for papers by Marion Ganslmayer Breakdown of academic impact, for papers by Jaehwi Song Breakdown of academic impact, for papers by Steven V. Molinski Breakdown of academic impact, for papers by Reyaz ur Rasool Breakdown of academic impact, for papers by Khurum Khan Breakdown of academic impact, for papers by Yusuke Nakamura Breakdown of academic impact, for papers by Guadalupe Domínguez-Gómez Breakdown of academic impact, for papers by Kimberly L. Moulton Breakdown of academic impact, for papers by Katharina R. Beck
Rankless by CCL
2026